Oxford BioDynamics (Oxford BioDynamics) COGS-to-Revenue : 0.58 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics COGS-to-Revenue?

Oxford BioDynamics's Cost of Goods Sold for the six months ended in Sep. 2023 was $0.21 Mil. Its Revenue for the six months ended in Sep. 2023 was $0.36 Mil.

Oxford BioDynamics's COGS to Revenue for the six months ended in Sep. 2023 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Oxford BioDynamics's Gross Margin % for the six months ended in Sep. 2023 was 42.06%.

Oxford BioDynamics COGS-to-Revenue Historical Data

The historical data trend for Oxford BioDynamics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics COGS-to-Revenue Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

COGS-to-Revenue

Get a 7-Day Free Trial

0.52

1.36

0.25

0.48

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
COGS-to-Revenue	Get a 7-Day Free Trial														-6.61	-	0.55	0.34	0.58

Oxford BioDynamics COGS-to-Revenue Calculation

Oxford BioDynamics's COGS to Revenue for the fiscal year that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.302	/	0.631
	=	0.48

Oxford BioDynamics's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.208	/	0.359
	=	0.58

Oxford BioDynamics (OTCPK:OXBOF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Oxford BioDynamics's Gross Margin % for the six months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.208 / 0.359
	=	42.06 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Oxford BioDynamics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (Oxford BioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

OBD:UK

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.